Cargnin Faccin, F., Gay, L.C., Regmi, D. et al. Sequential aerosol and oral immunization with a bivalent H9N2/H5N2 vaccine protects against H5N1 and H9N2 avian influenza challenges. npj Vaccines (2025)
Avian influenza continues to be a major threat to poultry and public health. This study investigated the efficacy of a bivalent H9N2/H5N2 modified live virus (MLV) vaccine delivered through a sequential aerosol priming and drinking water boosting in chickens. We hypothesized that this vaccination strategy would induce robust protective immunity against both low pathogenic H9N2 and high pathogenic H5N1 avian influenza viruses. The results demonstrated that the bivalent MLV vaccine provided sterilizing immunity against homologous and antigenically drifted H9N2 virus challenges. While anti-H5 antibody responses after MLV vaccination were generally weak, a robust anti-N2 antibody response was observed. Notably, the bivalent MLV prime-boost group demonstrated 90% survival against a high-dose H5N1 HPAI challenge. These findings highlight the potential of this mass vaccination approach, utilizing aerosol delivery complemented by drinking water administration, as a convenient and cost-effective method for avian influenza control, particularly H9N2 and H5N1 HPAI.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 6 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 6 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 7 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 7 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 7 hours ago
[Go Top] [Close Window]


